Syntekabio is based in Daejeon, South Korea. It has raised $11M in total funding. Latest round: Post IPO.
Syntekabio funding overview
Syntekabio is based in Daejeon, South Korea. Syntekabio has raised $11M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Post IPO announced in April 2024. The round record for Syntekabio runs through 2024; nothing later has been disclosed. Investors on record include Korea Development Bank Europe, Altos Ventures Management, Smile Gate Investment, Korea Investment Partners. 4 distinct backers are named across the disclosed rounds.
Syntekabio at a glance
Total raised
$11M
Latest round
Post IPO
Latest round date
April 2024
Headquarters
Daejeon, South Korea
Notable investors
Korea Development Bank Europe, Altos Ventures Management, Smile Gate Investment, Korea Investment Partners
Frequently asked about Syntekabio funding
How much has Syntekabio raised?
Syntekabio has raised $11M in total disclosed funding across the rounds on record.
Who has invested in Syntekabio?
Korea Development Bank Europe, Altos Ventures Management, Smile Gate Investment, Korea Investment Partners are named among the investors backing Syntekabio.
What was the latest Syntekabio funding round?
The most recent disclosed round is a Post IPO, announced in April 2024.
Where is Syntekabio based?
Syntekabio is based in Daejeon, South Korea.
When did Syntekabio last raise?
The last disclosed Syntekabio round closed in April 2024 at Post IPO.
Totals shown for Syntekabio aggregate every disclosed round on file. To see how that compares, browse the companies in Daejeon and the investors behind them below.
